Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis C

  Free Subscription


30.12.2018

1 Clin Res Hepatol Gastroenterol
1 Eur J Gastroenterol Hepatol
1 J Med Virol
2 J Viral Hepat
5 PLoS One
1 Transplant Proc


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Clin Res Hepatol Gastroenterol

  1. CUNHA LRD, Vieira DA, Giampietro YG, Gomes AD, et al
    Interleukin-10 promoter gene polymorphisms are associated with the first major depressive episode in chronic hepatitis C patients.
    Clin Res Hepatol Gastroenterol. 2018 Dec 24. pii: S2210-7401(18)30276.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  2. MARCELLIN F, Protopopescu C, Wittkop L, Salmon-Ceron D, et al
    No influence of cannabis use on liver stiffness in HIV-HCV co-infected patients (ANRS CO13 HEPAVIH cohort study).
    Eur J Gastroenterol Hepatol. 2019;31:274-276.
    PubMed     Text format    


    J Med Virol

  3. BAVARO DF, Saracino A, Fiordelisi D, Bruno G, et al
    Influence of HLA-B18 on liver fibrosis progression in a cohort of HIV/HCV co-infected individuals.
    J Med Virol. 2018 Dec 22. doi: 10.1002/jmv.25385.
    PubMed     Text format     Abstract available


    J Viral Hepat

  4. RODRIGO C, Leung P, Lloyd AR, Bull RA, et al
    Genomic variability of within-host hepatitis C variants in acute infection.
    J Viral Hepat. 2018 Dec 22. doi: 10.1111/jvh.13051.
    PubMed     Text format     Abstract available

  5. RAMACHANDRAN J, Budd S, Slattery H, Muller K, et al
    Hepatitis C virus infection in Australian psychiatric in-patients: a multicenter study of seroprevalence, risk factors and treatment experience.
    J Viral Hepat. 2018 Dec 21. doi: 10.1111/jvh.13056.
    PubMed     Text format     Abstract available


    PLoS One

  6. PAPIC N, Zidovec Lepej S, Gorenec L, Grgic I, et al
    The association of semaphorins 3C, 5A and 6D with liver fibrosis stage in chronic hepatitis C.
    PLoS One. 2018;13:e0209481.
    PubMed     Text format     Abstract available

  7. KAWAGISHI N, Suda G, Nakamura A, Kimura M, et al
    Liver steatosis and dyslipidemia after HCV eradication by direct acting antiviral agents are synergistic risks of atherosclerosis.
    PLoS One. 2018;13:e0209615.
    PubMed     Text format     Abstract available

  8. LIU CH, Liu CJ, Su TH, Yang HC, et al
    Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan.
    PLoS One. 2018;13:e0209299.
    PubMed     Text format     Abstract available

  9. EVANS H, Balasegaram S, Douthwaite S, Hunter L, et al
    An innovative approach to increase viral hepatitis diagnoses and linkage to care using opt-out testing and an integrated care pathway in a London Emergency Department.
    PLoS One. 2018;13:e0198520.
    PubMed     Text format     Abstract available

  10. MATSUMOTO K, Wu Y, Kitazawa T, Fujita S, et al
    Cost of illness of hepatocellular carcinoma in Japan: A time trend and future projections.
    PLoS One. 2018;13:e0199188.
    PubMed     Text format     Abstract available


    Transplant Proc

  11. JUNG BH, Park JI, Lee SG
    Successful Treatment of Fibrosing Cholestatic Hepatitis With Daclatasvir and Asunaprevir After Liver Transplantation: A Case Report.
    Transplant Proc. 2018;50:2877-2881.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: